Molecular Mechanisms of Mesenchymal Stem Cell-Based Therapy in Acute Kidney Injury

Acute kidney injury (AKI) causes a lot of harm to human health but is treated by only supportive therapy in most cases. Recent evidence shows that mesenchymal stem cells (MSCs) benefit kidney regeneration through releasing paracrine factors and extracellular vesicles (EVs) to the recipient kidney ce...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pei-Wen Lee, Bo-Sheng Wu, Chih-Yu Yang, Oscar Kuang-Sheng Lee
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/12bd90d7e5c54f7d92ec637504c44e8f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:12bd90d7e5c54f7d92ec637504c44e8f
record_format dspace
spelling oai:doaj.org-article:12bd90d7e5c54f7d92ec637504c44e8f2021-11-11T16:52:51ZMolecular Mechanisms of Mesenchymal Stem Cell-Based Therapy in Acute Kidney Injury10.3390/ijms2221114061422-00671661-6596https://doaj.org/article/12bd90d7e5c54f7d92ec637504c44e8f2021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11406https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Acute kidney injury (AKI) causes a lot of harm to human health but is treated by only supportive therapy in most cases. Recent evidence shows that mesenchymal stem cells (MSCs) benefit kidney regeneration through releasing paracrine factors and extracellular vesicles (EVs) to the recipient kidney cells and are considered to be promising cellular therapy for AKI. To develop more efficient, precise therapies for AKI, we review the therapeutic mechanism of MSCs and MSC-derived EVs in AKI and look for a better understanding of molecular signaling and cellular communication between donor MSCs and recipient kidney cells. We also review recent clinical trials of MSC-EVs in AKI. This review summarizes the molecular mechanisms of MSCs’ therapeutic effects on kidney regeneration, expecting to comprehensively facilitate future clinical application for treating AKI.Pei-Wen LeeBo-Sheng WuChih-Yu YangOscar Kuang-Sheng LeeMDPI AGarticleacute kidney injurymesenchymal stem cellsextracellular vesiclesBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11406, p 11406 (2021)
institution DOAJ
collection DOAJ
language EN
topic acute kidney injury
mesenchymal stem cells
extracellular vesicles
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle acute kidney injury
mesenchymal stem cells
extracellular vesicles
Biology (General)
QH301-705.5
Chemistry
QD1-999
Pei-Wen Lee
Bo-Sheng Wu
Chih-Yu Yang
Oscar Kuang-Sheng Lee
Molecular Mechanisms of Mesenchymal Stem Cell-Based Therapy in Acute Kidney Injury
description Acute kidney injury (AKI) causes a lot of harm to human health but is treated by only supportive therapy in most cases. Recent evidence shows that mesenchymal stem cells (MSCs) benefit kidney regeneration through releasing paracrine factors and extracellular vesicles (EVs) to the recipient kidney cells and are considered to be promising cellular therapy for AKI. To develop more efficient, precise therapies for AKI, we review the therapeutic mechanism of MSCs and MSC-derived EVs in AKI and look for a better understanding of molecular signaling and cellular communication between donor MSCs and recipient kidney cells. We also review recent clinical trials of MSC-EVs in AKI. This review summarizes the molecular mechanisms of MSCs’ therapeutic effects on kidney regeneration, expecting to comprehensively facilitate future clinical application for treating AKI.
format article
author Pei-Wen Lee
Bo-Sheng Wu
Chih-Yu Yang
Oscar Kuang-Sheng Lee
author_facet Pei-Wen Lee
Bo-Sheng Wu
Chih-Yu Yang
Oscar Kuang-Sheng Lee
author_sort Pei-Wen Lee
title Molecular Mechanisms of Mesenchymal Stem Cell-Based Therapy in Acute Kidney Injury
title_short Molecular Mechanisms of Mesenchymal Stem Cell-Based Therapy in Acute Kidney Injury
title_full Molecular Mechanisms of Mesenchymal Stem Cell-Based Therapy in Acute Kidney Injury
title_fullStr Molecular Mechanisms of Mesenchymal Stem Cell-Based Therapy in Acute Kidney Injury
title_full_unstemmed Molecular Mechanisms of Mesenchymal Stem Cell-Based Therapy in Acute Kidney Injury
title_sort molecular mechanisms of mesenchymal stem cell-based therapy in acute kidney injury
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/12bd90d7e5c54f7d92ec637504c44e8f
work_keys_str_mv AT peiwenlee molecularmechanismsofmesenchymalstemcellbasedtherapyinacutekidneyinjury
AT boshengwu molecularmechanismsofmesenchymalstemcellbasedtherapyinacutekidneyinjury
AT chihyuyang molecularmechanismsofmesenchymalstemcellbasedtherapyinacutekidneyinjury
AT oscarkuangshenglee molecularmechanismsofmesenchymalstemcellbasedtherapyinacutekidneyinjury
_version_ 1718432222993711104